mesalazine

The medicinal product contains mesalazine and is used to treat ulcerative colitis and Crohn's disease (long-term inflammatory bowel diseases) and unclassified inflammatory bowel disease (IBD-U). It is used both to treat active phases of the disease and to prevent flare-ups.

Form: tablets, enteric-coated

ATC: A07EC02

Manufacturer: DICOFARM S.P.A.

The medicine contains mesalazine and is an intestinal anti-inflammatory used to treat ulcerative colitis and Crohn's disease, as well as idiopathic inflammatory bowel disease (IBDU). It is used both to treat active phases of the disease and to prevent relapses.

Form: tablets, enteric-coated

ATC: A07EC02

Manufacturer: GIULIANI SPA

Asalex is indicated for the treatment of intestinal inflammation (such as ulcerative colitis, Crohn's disease, and unclassifiable inflammatory bowel disease) and to prevent relapses.

Form: suspension, rectal

ATC: A07EC02

Manufacturer: CHIESI FARMACEUTICI S.P.A.

ASAMAX is indicated for the treatment of intestinal inflammation (such as ulcerative colitis and Crohn's disease) and for the prevention of relapses. Depending on the pharmaceutical form, it can be used to treat inflammation at the rectal or rectosigmoid level.

Form: tablets, enteric-coated

ATC: A07EC02

Manufacturer: CA.DI. GROUP S.P.A.

It is used for the treatment and prevention of inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease.

Form: tablets, film-coated

ATC: A07EC02

Manufacturer: VIATRIS ITALIA S.R.L.

It is used to treat intestinal inflammation (ulcerative colitis and Crohn's disease), both during the active phase of the disease and to prevent relapses.

Form: tablets, film-coated

ATC: A07EC02

Manufacturer: TEOFARMA S.R.L.

Cletrova is an anti-inflammatory used for the treatment of acute episodes and for the prevention of further episodes (relapses) of ulcerative colitis, a mild to moderate inflammatory disease of the large intestine (colon).

Form: granules, extended release

ATC: A07EC02

Manufacturer: DR. FALK PHARMA GMBH

The medicine contains mesalazine and is used for the treatment of ulcerative colitis and Crohn's disease (long-term inflammatory bowel diseases). It is used both to treat the ongoing disease and to prevent relapses.

Form: tablets, enteric-coated

ATC: A07EC02

Manufacturer: DOC GENERICI SRL

It is used to reduce symptoms and prevent complications and relapses in diseases such as Ulcerative Colitis and Crohn's Disease, which are characterized by intestinal inflammation.

Form: tablets, enteric-coated

ATC: A07EC02

Manufacturer: TEVA ITALIA S.R.L.

This medicine is an intestinal anti-inflammatory used to treat ulcerative colitis, Crohn's disease, and idiopathic inflammatory bowel disease (IBDU). It is used both to treat active phases of the disease and to prevent relapses.

Form: capsules, modified release, hard

ATC: A07EC02

Manufacturer: EG S.P.A.

It is used to treat inflammatory bowel diseases, specifically ulcerative colitis and Crohn's disease. It is used both to treat the ongoing disease and to prevent relapses.

Form: tablets, enteric-coated

ATC: A07EC02

Manufacturer: MYLAN S.P.A.

It is used to treat intestinal inflammation (such as ulcerative colitis and Crohn's disease) and to prevent relapses. The rectal suspension version is indicated for ulcerative colitis localized in the rectal region.

Form: tablets, film-coated

ATC: A07EC02

Manufacturer: SANDOZ S.P.A.

MESAVANCOL contains mesalazine, an anti-inflammatory drug used for the treatment of ulcerative colitis (a disease of the colon and rectum that causes inflammation, cramping, and bloody stools). It can be used both to treat an acute episode and to prevent the recurrence of the disease.

Form: tablets, prolonged-release

ATC: A07EC02

Manufacturer: GIULIANI SPA

It is used for the treatment of chronic inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease, or intestinal inflammations of unknown cause. It is used both to treat the active phase of the disease and to prevent its recurrence.

Form: suspension, rectal, powder for preparation of

ATC: A07EC02

Manufacturer: ALFASIGMA S.P.A.

The drug contains mesalazine and is an intestinal anti-inflammatory used for the treatment of ulcerative colitis and Crohn's disease. Depending on the formulation, it may also be used for ulcerative proctitis (inflammation of the rectum).

Form: suspension, rectal

ATC: A07EC02

Manufacturer: FERRING S.P.A.

It is used to treat certain chronic inflammatory bowel diseases (such as ulcerative proctitis and Crohn's disease) and other acute or chronic inflammations localized in the lower part of the intestine or in the area around the anus. It is indicated both for treating active phases of the disease and for preventing relapses.

Form: gel, rectal

ATC: A07EC02

Manufacturer: GIULIANI SPA